1h Free Analyst Time
The lipid nanoparticles market is forecasted to grow by USD 74.9 million during 2023-2028, accelerating at a CAGR of 5.3% during the forecast period. The report on the lipid nanoparticles market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of innovative lnp formulation services, approvals for clinical trials, and rise in chronic diseases.
The lipid nanoparticles market is segmented as below:
By Type
- Solid lipid nanoparticles (SLNs)
- Nanostructured lipid carriers (NLCs)
- Others
By Product
- Ionizable lipids
- Phospho lipids
- Neutral lipids
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the lipid nanoparticles market covers the following areas:
- Lipid Nanoparticles Market sizing
- Lipid Nanoparticles Market forecast
- Lipid Nanoparticles Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Product
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global lipid nanoparticles market: Abbott Laboratories, Acuitas Therapeutics, Avanti Polar Lipids, Biopharma PEG Scientific Inc., Corden Pharma International GmbH, Creative Biolabs, Curapath, Evonik Industries AG, FUJIFILM Holdings Corporation, GATTEFOSSE SAS, INTEGRATED NANOTHERAPEUTICS INC, Merck KGaA, NOF CORP., Organix INC, Pantherna Therapeutics GmbH, Polysciences Inc., Precision NanoSystems Inc, and VION Biosciences LLC.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is product launches."
According to the report, one of the major drivers for this market is the development of innovative lnp formulation services.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Acuitas Therapeutics
- Avanti Polar Lipids
- Biopharma PEG Scientific Inc.
- Corden Pharma International GmbH
- Creative Biolabs
- Curapath
- Evonik Industries AG
- FUJIFILM Holdings Corporation
- GATTEFOSSE SAS
- INTEGRATED NANOTHERAPEUTICS INC
- Merck KGaA
- NOF CORP.
- Organix INC
- Pantherna Therapeutics GmbH
- Polysciences Inc.
- Precision NanoSystems Inc
- VION Biosciences LLC
